|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Konturek PC, Konturek SJ and Brzozowski T:
Helicobacter pylori infection in gastric cancerogenesis. J
Physiol Pharmacol. 60:3–21. 2009.
|
|
3
|
Polk DB and Peek RM Jr: Helicobacter
pylori: gastric cancer and beyond. Nat Rev Cancer. 10:403–414.
2010. View
Article : Google Scholar
|
|
4
|
Ding SZ, Smith MF Jr and Goldberg JB:
Helicobacter pylori and mitogen-activated protein kinases
regulate the cell cycle, proliferation and apoptosis in gastric
epithelial cells. J Gastroenterol Hepatol. 23:e67–e78. 2008.
View Article : Google Scholar
|
|
5
|
Chen YC, Wang Y, Li JY, Xu WR and Zhang
YL: H. pylori stimulates proliferation of gastric cancer
cells through activating mitogen-activated protein kinase cascade.
World J Gastroenterol. 12:5972–5977. 2006.
|
|
6
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brandt S, Kwok T, Hartig R, König W and
Backert S: NF-kappaB activation and potentiation of proinflammatory
responses by the Helicobacter pylori CagA protein. Proc Natl
Acad Sci USA. 102:9300–9305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Q, Liu N, Shen B, et al:
Helicobacter pylori enhances cyclooxygenase 2 expression via
p38MAPK/ATF-2 signaling pathway in MKN45 cells. Cancer Lett.
278:97–103. 2009. View Article : Google Scholar
|
|
10
|
Wang G, Gao F, Zhang W, et al: Involvement
of Aquaporin 3 in Helicobacter pylori-related gastric
diseases. PLoS One. 7:e491042012.
|
|
11
|
de Paulis A, Prevete N, Rossi FW, et al:
Helicobacter pylori Hp(2–20) promotes migration and
proliferation of gastric epithelial cells by interacting with
formyl peptide receptors in vitro and accelerates gastric mucosal
healing in vivo. J Immunol. 183:3761–3769. 2009.
|
|
12
|
Nagy TA, Wroblewski LE, Wang D, et al:
β-Catenin and p120 mediate PPARδ-dependent proliferation induced by
Helicobacter pylori in human and rodent epithelia.
Gastroenterology. 141:553–564. 2011.
|
|
13
|
Zhao D, Liu Z, Ding J, et al:
Helicobacter pylori CagA upregulation of CIP2A is dependent
on the Src and MEK/ERK pathways. J Med Microbiol. 59:259–265. 2009.
View Article : Google Scholar
|
|
14
|
Seshacharyulu P, Pandey P, Datta K and
Batra SK: Phosphatase: PP2A structural importance, regulation and
its aberrant expression in cancer. Cancer Lett. 335:9–18. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Junttila MR, Puustinen P, Niemelä M, et
al: CIP2A inhibits PP2A in human malignancies. Cell. 130:51–62.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li W, Ge Z, Liu C, et al: CIP2A is
overexpressed in gastric cancer and its depletion leads to impaired
clonogenicity, senescence, or differentiation of tumor cells. Clin
Cancer Res. 14:3722–3728. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Khanna A, Böckelman C, Hemmes A, et al:
MYC-dependent regulation and prognostic role of CIP2A in gastric
cancer. J Natl Cancer Inst. 101:793–805. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mathiasen DP, Egebjerg C, Andersen SH, et
al: Identification of a c-Jun N-terminal kinase-2-dependent signal
amplification cascade that regulates c-Myc levels in ras
transformation. Oncogene. 31:390–401. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wandler AM and Guillemin K: Transgenic
expression of the Helicobacter pylori virulence factor CagA
promotes apoptosis or tumorigenesis through JNK activation in
Drosophila. PLoS Pathog. 8:e10029392012.PubMed/NCBI
|
|
20
|
Thun MJ, DeLancey JO, Center MM, Jemal A
and Ward EM: The global burden of cancer: priorities for
prevention. Carcinogenesis. 31:100–110. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fock KM and Ang TL: Epidemiology of
Helicobacter pylori infection and gastric cancer in Asia. J
Gastroenterol Hepatol. 25:479–486. 2010.
|
|
22
|
Zhang DH, Zhou LY, Lin SR, et al: Recent
changes in the prevalence of Helicobacter pylori infection
among children and adults in high- or low-incidence regions of
gastric cancer in China. Chin Med J (Engl). 122:1759–1763.
2009.PubMed/NCBI
|
|
23
|
Wang XQ, Yan H, Terry PD, et al:
Interaction between dietary factors and Helicobacter pylori
infection in noncardia gastric cancer: a population-based
case-control study in China. J Am Coll Nutr. 31:375–384. 2012.
|
|
24
|
Zhang Y, Sun LP, Xing CZ, et al:
Interaction between GSTP1 Val allele and H. pylori
infection, smoking and alcohol consumption and risk of gastric
cancer among the Chinese population. PLoS One.
7:e471782012.PubMed/NCBI
|
|
25
|
Epplein M, Zheng W, Xiang YB, et al:
Prospective study of Helicobacter pylori biomarkers for
gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers
Prev. 21:2185–2192. 2012.
|
|
26
|
Fukase K, Kato M, Kikuchi S, et al: Effect
of eradication of Helicobacter pylori on incidence of
metachronous gastric carcinoma after endoscopic resection of early
gastric cancer: an open-label, randomised controlled trial. Lancet.
372:392–397. 2008.PubMed/NCBI
|
|
27
|
Fuccio L, Zagari RM, Eusebi LH, et al:
Meta-analysis: can Helicobacter pylori eradication treatment
reduce the risk for gastric cancer? Ann Intern Med. 151:121–128.
2009.
|
|
28
|
Jang SH, Lim JW and Kim H: Beta-carotene
inhibits Helicobacter pylori-induced expression of inducible
nitric oxide synthase and cyclooxygenase-2 in human gastric
epithelial AGS cells. J Physiol Pharmacol. 60(Suppl 7): S131–S137.
2009.
|
|
29
|
Lim JW and Kim H: Role of
protease-activated receptor-2 on cell death and DNA fragmentation
in Helicobacter pylori-infected gastric epithelial cells. J
Transl Med. 8:852010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao C, Ma H, Bu X, Wang W and Zhang N:
SFRP5 inhibits gastric epithelial cell migration induced by
macrophage-derived Wnt5a. Carcinogenesis. 34:146–152. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhong J, Zhao M, Luo Q, et al: CCDC134 is
down-regulated in gastric cancer and its silencing promotes cell
migration and invasion of GES-1 and AGS cells via the MAPK pathway.
Mol Cell Biochem. 372:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi IJ, Fujimoto S, Yamauchi K, Graham DY
and Yamaoka Y: Helicobacter pylori environmental
interactions: effect of acidic conditions on H.
pylori-induced gastric mucosal interleukin-8 production. Cell
Microbiol. 9:2457–2469. 2007. View Article : Google Scholar
|
|
33
|
Ding S-Z, Olekhnovich IN, Cover TL, Peek
RM Jr, Smith MF Jr and Goldberg JB: Helicobacter pylori and
mitogen-activated protein kinases mediate activator protein-1
(AP-1) subcomponent protein expression and DNA-binding activity in
gastric epithelial cells. FEMS Immunol Med Microbiol. 53:385–394.
2008. View Article : Google Scholar
|
|
34
|
Matsumoto A, Isomoto H, Nakayama M, et al:
Helicobacter pylori VacA reduces the cellular expression of
STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL,
leading to apoptosis in gastric epithelial cells. Dig Dis Sci.
56:999–1006. 2011. View Article : Google Scholar
|
|
35
|
Ke H, Harris R, Coloff JL, et al: The
c-Jun NH2-terminal kinase 2 plays a dominant role in human
epidermal neoplasia. Cancer Res. 70:3080–3088. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cellurale C, Sabio G, Kennedy NJ, et al:
Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor
formation. Mol Cell Biol. 31:1565–1576. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li N, Han L, Chen J, Lin X, Chen H and She
F: Proliferative and apoptotic effects of gastric epithelial cells
induced by coccoidHelicobacter pylori. J Basic Microbiol.
53:147–155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Feng Y, Wang L, Zeng J, et al: FoxM1 is
overexpressed in Helicobacter pylori-induced gastric
carcinogenesis and is negatively regulated by miR-370. Mol Cancer
Res. 11:834–844. 2013.
|
|
39
|
Himaya SWA, Dewapriya P and Kim SK: EGFR
tyrosine kinase inhibitory peptide attenuates Helicobacter
pylori-mediated hyper-proliferation in AGS enteric epithelial
cells. Toxicol Appl Pharmacol. 269:205–214. 2013. View Article : Google Scholar : PubMed/NCBI
|
